Clinical trials: Crohn Disease (CD)

Pediatric Crohn's Disease

Post-Marketing Surveillance of Humira in Korean Pediatric Crohn's Disease (CD) Patients Under the "New-Drug Re-examination"

• Completed
• Age: 6 to 17 years
• Observational study
• Results posted

This study is a non-interventional, observational study of Humira® in the treatment of pediatric CD as per the New Drug Re-examination Guideline in Korea.

Trial name

NCT02578238

Volunteers

143 people

Sponsor

AbbVie